Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Lung Cancer - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

  • Treating Lung Cancer in Nonsmokers and Former Light Smokers
    (Posted: 01/09/2007) - In this trial, previously untreated non-small cell lung cancer patients who never smoked or are former light smokers will be treated with either erlotinib alone or erlotinib in combination with the drugs carboplatin and paclitaxel.
  • Gene Therapy for Metastatic Cancer
    (Posted: 11/21/2006) - In the trial, researchers will harvest normal T lymphocytes from patients' blood and modify these immune system cells to recognize p53 protein, a common hallmark of many cancers. The modified cells will be enriched in the laboratory and then infused back into the patients.
  • Combining Targeted Therapies for Thoracic Cancers
    (Posted: 09/26/2006) - In this trial, patients with advanced thoracic cancers (cancers of the chest) or other cancers that have spread to the chest will be treated with the drugs romidepsin and flavopiridol. Researchers will study the safety of this combination and how these agents affect gene and protein expression in these patients.
  • Gefitinib for Non-Small Cell Lung Cancer Trial
    (Posted: 01/07/2004) - Researchers with this study seek to assess the effectiveness of gefitinib (Iressa) in prolonging the survival of patients who have undergone surgery for stage IB, II, or IIIA non-small cell lung cancer.
< Previous  1 2 3